Postnatat administrationofzidovudinetohebabyv
Oratzdovudinefrom28 weeks' gestation onwards canreducethe
riskoftransmission.A ranaeof studies suqqest that zidovudinei
effectiveinreducinatherskofHvtransmissionfrom motherto
neonatebv83%to18%.Theoptimaureaimenistocommence
zidovudineasanintravenous infusionattheonsetofuabourand
continuetreatment in the neonateupto6weeks of age.Therei
insufficientevidencethat intravenous zdovudinedurinqlabourisof
anv benefit.unessfouowed bv treatmemt ofthechidinthepostnatat
period.
@1MIN NDOCRINE
